Bausch + Lomb (BLCO) announced the commercial launch of the enVista Aspire monofocal and toric intraocular lenses in the European Union after receiving a CE Mark late last year. enVista Aspire ...
efficient unfolding through Bausch + Lomb’s proprietary StableFlex ™ Technology, which aids optic recovery. For patients with astigmatism, enVista Aspire Toric IOLs provide a proven option for ...
Bausch + Lomb Corporation (NYSE/TSX ... today announced the commercial launch of the enVista Aspire monofocal and toric intraocular lenses (IOLs) in the European Union after receiving a CE ...
efficient unfolding through Bausch + Lomb’s proprietary StableFlex ™ Technology, which aids optic recovery. For patients with astigmatism, enVista Aspire Toric IOLs provide a proven option for ...
In the US, enVista Aspire is the first Low-Cyl toric IOL below 1.5D at the IOL plane, enhancing treatment options. Bausch + Lomb announced the commercial launch of its enVista Aspire monofocal and ...
VAUGHAN, Ontario — Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the commercial launch of the ...
Bausch + Lomb launched the enVista Aspire monofocal and toric IOLs in the European Union, according to a press release.Using intermediate optimized optics, the lenses offer a range of vision beyond ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback